サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454099

心膜疾患市場：タイプ別、診断方法別、治療アプローチ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、予測、2024-2032年

Pericardium Diseases Market, By Type, By Diagnosis Method, By Treatment Approach, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 285 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
心膜疾患市場：タイプ別、診断方法別、治療アプローチ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月11日
発行: AnalystView Market Insights
ページ情報: 英文 285 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

心膜疾患市場規模は2023年に24億4,100万米ドルとなり、2024年から2032年にかけてCAGR 5.7％で拡大

心膜疾患市場-市場力学

心血管疾患の有病率の増加が市場の成長を支配すると予測

座りがちなライフスタイル、食生活の乱れ、高齢化などが原因で、心血管疾患の有病率は世界的に上昇傾向にあります。その結果、心膜疾患の診断および治療オプションに対するニーズが急増すると予想されます。世界保健機関（WHO）の報告によると、心血管系疾患（CVD）は世界の死亡の主因であり、年間約1,790万人の命を奪っています。研究開発への継続的な投資は市場拡大の可能性を秘めています。とはいえ、治療に伴う高額な費用が市場の成長を阻害する可能性もあります。

心膜疾患市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）においてCAGR約5.7%で年間成長すると予測されています。

市場セグメンテーションでは、非ステロイド性抗炎症薬（NSAIDS）が2023年に最大の市場シェアを示すと予測されています。

治療アプローチ別では、非ステロイド性抗炎症薬（NSAIDS）製剤が2023年の主要タイプでした。

エンドユーザー別では、病院と診療所が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

心膜疾患市場-セグメンテーション分析：

世界の心膜疾患市場は、タイプ、診断方法、治療アプローチ、エンドユーザー、地域に基づいてセグメント化されます。

市場は治療アプローチによって2つのグループに分類される：急性心膜炎、血性心膜炎、心膜炎、結核性心膜炎です。市場を独占しているのは急性心膜炎です。急性心膜炎は、突然発症する心膜の炎症が特徴で、多くの場合、胸痛、発熱、呼吸困難などの症状を引き起こします。

市場は診断方法によって5つのカテゴリーに区分される：胸部X線、心臓MRI、心臓CTスキャン、心エコー、心電図、その他（血液検査）。心膜疾患の評価には、心膜と心臓の両方の評価を助ける様々な技術が含まれます。

市場は治療アプローチに基づいて2つのカテゴリーに分けられる：非ステロイド性抗炎症薬（NSAIDs）と心膜切除術です。非ステロイド性抗炎症薬（NSAIDS）セグメントは市場を独占しています。非ステロイド性抗炎症薬（NSAIDs）は、急性心膜炎などの疾患の管理および治療において重要な役割を果たしています。

市場はエンドユーザーによって、病院・診療所、外来センター、その他の2つのセグメントに分類されます。市場の支配的なセグメントは病院・診療所です。これらの医療施設は、急性心膜炎、心嚢液貯留、収縮性心膜炎、心膜タンポナーデなど、さまざまな心膜疾患の患者に必要不可欠な医療サービスを提供する上で重要な役割を果たしています。

心膜疾患市場-地理的洞察

市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカに地理的に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。市場の成長を支配しているのは北米で、その主な理由は医療支出の増加です。北米は、高度な医療インフラ、最先端の医療施設、一流の研究機関、高度に熟練した医療専門家を誇りとしています。メディケア・メディケイド・サービスセンターによると、米国の医療支出は2022年に4.1％増加し、4兆5,000億米ドル、1人当たり1万3,493米ドルに達しました。医療費は国内総生産の17.3％を占めています。欧州は、心膜疾患管理の需要増に牽引され、市場成長において第2位の地域となっています。

心膜疾患市場-競合情勢：

心膜疾患市場には、心臓を包む保護嚢である心膜に影響を与えるさまざまな疾患が含まれます。製薬企業やバイオテクノロジー企業は、これらの疾患に対する新たな治療法の開発を目指し、激しい競争を繰り広げています。これらの企業は、治験薬の安全性と有効性を実証するために大規模な前臨床試験と臨床試験に投資し、規制当局の承認を得て、この治療分野で大きな市場シェアを獲得することを最終目標としています。競合は製品開拓にとどまらず、市場参入や償還の戦略にも及んでいます。各社は、患者や医療プロバイダーが自社製品を容易に入手できるよう、支払者から有利な処方や償還の適用を確保するために競争しています。

目次

第1章 心膜疾患市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 心膜疾患の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 心膜疾患業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 心膜疾患市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 心膜疾患市場情勢

  • 心膜疾患市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 心膜疾患市場-タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • 急性心膜炎
    • 血心膜
    • 心膜炎
    • 結核性心膜炎

第8章 心膜疾患市場-診断方法別

  • 概要
    • 診断方法別のセグメントシェア分析
    • 胸部X線
    • 心臓MRI
    • 心臓CTスキャン
    • 心エコー検査
    • 心電図検査（EKG）
    • その他（血液検査）

第9章 心膜疾患市場-治療アプローチ別

  • 概要
    • 治療アプローチ別のセグメントシェア分析
    • 非ステロイド性抗炎症薬（NSAIDs）
    • 心膜切除術

第10章 心膜疾患市場-エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院と診療所
    • 外来センター
    • その他

第11章 心膜疾患市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-心膜疾患業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Kiniksa Pharmaceuticals
    • Pfizer Inc.
    • Medtronic
    • Bayer AG
    • AstraZeneca Plc
    • Sanofi
    • Johnson and Johnson Services, Inc.
    • Merck &Co., Inc.
    • Allergan Plc.
    • Novartis AG
    • Perkin Elmer Inc.
    • Integra Lifesciencesk
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pericardium Diseases Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Pericardium Diseases Market, by Type 2019-2032 (USD Million)
  • TABLE Pericardium Diseases Market: Diagnosis Method Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnosis Method
  • TABLE Global Pericardium Diseases Market, by Diagnosis Method 2019-2032 (USD Million)
  • TABLE Pericardium Diseases Market: Treatment Approach Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Approach
  • TABLE Global Pericardium Diseases Market, by Treatment Approach 2019-2032 (USD Million)
  • TABLE Pericardium Diseases Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Pericardium Diseases Market, by End-User 2019-2032 (USD Million)
  • TABLE Pericardium Diseases Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pericardium Diseases Market, by Region 2019-2032 (USD Million)
  • TABLE North America Pericardium Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Pericardium Diseases Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Pericardium Diseases Market, by Diagnosis Method, 2019-2032 (USD Million)
  • TABLE North America Pericardium Diseases Market, by Treatment Approach, 2019-2032 (USD Million)
  • TABLE North America Pericardium Diseases Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Pericardium Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Pericardium Diseases Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Pericardium Diseases Market, by Diagnosis Method, 2019-2032 (USD Million)
  • TABLE Europe Pericardium Diseases Market, by Treatment Approach, 2019-2032 (USD Million)
  • TABLE Europe Pericardium Diseases Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pericardium Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pericardium Diseases Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pericardium Diseases Market, by Diagnosis Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pericardium Diseases Market, by Treatment Approach, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pericardium Diseases Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Pericardium Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Pericardium Diseases Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Pericardium Diseases Market, by Diagnosis Method, 2019-2032 (USD Million)
  • TABLE Latin America Pericardium Diseases Market, by Treatment Approach, 2019-2032 (USD Million)
  • TABLE Latin America Pericardium Diseases Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pericardium Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pericardium Diseases Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pericardium Diseases Market, by Diagnosis Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pericardium Diseases Market, by Treatment Approach, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pericardium Diseases Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Pericardium Diseases Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Diagnosis Method segment market share analysis, 2023 & 2032
  • FIGURE Diagnosis Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Treatment Approach segment market share analysis, 2023 & 2032
  • FIGURE Treatment Approach segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Pericardium Diseases Market share and leading players, 2023
  • FIGURE Europe Pericardium Diseases Market share and leading players, 2023
  • FIGURE Asia Pacific Pericardium Diseases Market share and leading players, 2023
  • FIGURE Latin America Pericardium Diseases Market share and leading players, 2023
  • FIGURE Middle East and Africa Pericardium Diseases Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Pericardium Diseases Market share analysis by country, 2023
  • FIGURE Germany Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Pericardium Diseases Market share analysis by country, 2023
  • FIGURE India Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Pericardium Diseases Market share analysis by country, 2023
  • FIGURE Brazil Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Pericardium Diseases Market share analysis by country, 2023
  • FIGURE Saudi Arabia Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Pericardium Diseases Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2280

REPORT HIGHLIGHT

Pericardium Diseases Market size was valued at USD 2,441 Million in 2023, expanding at a CAGR of 5.7% from 2024 to 2032.

Pericarditis is a prevalent medical issue characterized by inflammation of the pericardium, the delicate membrane enveloping the heart. Typically, there exists a small quantity of fluid between the inner and outer layers of the pericardium. In cases of inflammation, this fluid often increases. A significant accumulation of fluid can hinder the heart's ability to fill and operate effectively. Pericardial disease can either appear independently or as a symptom of a broader systemic ailment.

Pericardium Diseases Market- Market Dynamics

Increased prevalence of cardiovascular disorders is expected to dominate the growth of market

The prevalence of cardiovascular diseases is on the rise worldwide, attributed to sedentary lifestyles, poor dietary habits, and aging populations. Consequently, there is expected to be a surge in the need for diagnostic and therapeutic options for pericardial diseases. The World Health Organization reports that cardiovascular diseases (CVDs) are the primary cause of mortality globally, claiming approximately 17.9 million lives annually. Ongoing investments in research and development present potential for market expansion. Nevertheless, the high costs associated with treatment may impede market growth.

Pericardium Diseases Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.7% over the forecast period (2024-2032)

Based on Type segmentation, Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs was predicted to show maximum market share in the year 2023

Based on Treatment Approach segmentation, Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs was the leading type in 2023

Based on End-user Approach segmentation, hospitals and clinics was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pericardium Diseases Market- Segmentation Analysis:

The Global Pericardium Diseases Market is segmented on the basis of Type, Diagnosis Method, Treatment Approach, End-User, and Region.

The market is categorized into two groups according to the Treatment Approach: Acute pericarditis, Hemopericardium, Pericarditis and Tuberculous pericarditis. Acute pericarditis dominates the market. Acute pericarditis is characterized by sudden onset inflammation of the pericardium, often resulting in symptoms such as chest pain, fever, and difficulty breathing.

The market is segmented into five categories according to the Diagnosis Method: Chest X-Ray, Cardiac MRI, Cardiac CT Scan, Echocardiography, Electrocardiography (EKG), and Others (Blood Test). The evaluation of pericardium diseases encompasses a range of techniques that aid in the assessment of both the pericardium and the heart.

The market is divided into two categories based on Treatment Approach: Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs and Pericardiectomy. Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs segment dominates the market. nonsteroidal anti-inflammatory drugs (NSAIDs) play a crucial role in the management and treatment of conditions such as acute pericarditis.

The market is categorized into two segments based on the end user: hospitals and clinics, ambulatory centers, and others. The dominant segment in the market is hospitals and clinics. These healthcare facilities play a crucial role in providing essential healthcare services to patients with various pericardial conditions, such as acute pericarditis, pericardial effusion, constrictive pericarditis, and pericardial tamponade, among others.

Pericardium Diseases Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is dominated by North America, primarily due to the rising healthcare expenditure. North America takes pride in its advanced healthcare infrastructure, state-of-the-art medical facilities, leading research institutions, and highly skilled healthcare professionals. According to the Center for Medicare and Medicaid Services, healthcare spending in the United States grew by 4.1 percent in 2022, reaching USD4.5 trillion or USD13,493 per person. Health spending accounted for 17.3 percent of the nation's Gross Domestic Product. Europe holds the second-largest region for market growth, driven by the increased demand for pericardium disease management.

Pericardium Diseases Market- Competitive Landscape:

The pericardium diseases market encompasses a variety of conditions that impact the pericardium, the protective sac that surrounds the heart. Pharmaceutical and biotechnology companies engage in fierce competition as they strive to develop new therapies for these diseases. These companies invest in extensive preclinical and clinical studies to demonstrate the safety and effectiveness of their investigational drugs, with the ultimate goal of obtaining regulatory approvals and capturing a significant market share in this therapeutic field. The competition extends beyond the development of products and includes strategies for market access and reimbursement. Companies compete to secure favorable formulary placement and reimbursement coverage from payers, ensuring that their products are readily available to patients and healthcare providers.

Recent Developments:

In October 2023, Pfizer Inc. and BioNTech SE have reported encouraging top-line findings from a Phase 1/2 trial (NCT05596734) assessing the safety, tolerability, and immunogenicity of mRNA-based combination vaccine candidates targeting influenza and COVID-19 in a cohort of healthy adults aged 18 to 64 years.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERICARDIUM DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Kiniksa Pharmaceuticals

Pfizer Inc.

Medtronic

Bayer AG

AstraZeneca Plc

Sanofi

Johnson and Johnson Services, Inc.

Merck & Co., Inc.

Allergan Plc.

Novartis AG

Perkin Elmer Inc.

Integra Lifesciencesk

Others

GLOBAL PERICARDIUM DISEASES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Acute pericarditis
  • Hemopericardium
  • Pericarditis
  • Tuberculous pericarditis

GLOBAL PERICARDIUM DISEASES MARKET, BY DIAGNOSIS METHOD- MARKET ANALYSIS, 2019 - 2032

  • Chest X-Ray
  • Cardiac MRI
  • Cardiac CT Scan
  • Echocardiography
  • Electrocardiography (EKG)
  • Others (Blood Test)

GLOBAL PERICARDIUM DISEASES MARKET, BY TREATMENT APPROACH- MARKET ANALYSIS, 2019 - 2032

  • Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs
  • Pericardiectomy

GLOBAL PERICARDIUM DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospital & clinics
  • Ambulatory centers
  • Others

GLOBAL PERICARDIUM DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Pericardium Diseases Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Pericardium Diseases Market Snippet by Type
    • 2.1.2.Pericardium Diseases Market Snippet by Diagnosis Method
    • 2.1.3.Pericardium Diseases Market Snippet by Treatment Approach
    • 2.1.4.Pericardium Diseases Market Snippet by End-User
    • 2.1.5.Pericardium Diseases Market Snippet by Country
    • 2.1.6.Pericardium Diseases Market Snippet by Region
  • 2.2.Competitive Insights

3.Pericardium Diseases Key Market Trends

  • 3.1.Pericardium Diseases Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Pericardium Diseases Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Pericardium Diseases Market Opportunities
  • 3.4.Pericardium Diseases Market Future Trends

4.Pericardium Diseases Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Pericardium Diseases Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Pericardium Diseases Market Landscape

  • 6.1.Pericardium Diseases Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Pericardium Diseases Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Acute pericarditis
    • 7.1.3.Hemopericardium
    • 7.1.4.Pericarditis
    • 7.1.5.Tuberculous pericarditis

8.Pericardium Diseases Market - By Diagnosis Method

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Diagnosis Method, 2023 & 2032 (%)
    • 8.1.2.Chest X-Ray
    • 8.1.3.Cardiac MRI
    • 8.1.4.Cardiac CT Scan
    • 8.1.5.Echocardiography
    • 8.1.6.Electrocardiography (EKG)
    • 8.1.7.Others (Blood Test)

9.Pericardium Diseases Market - By Treatment Approach

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Treatment Approach, 2023 & 2032 (%)
    • 9.1.2.Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs
    • 9.1.3.Pericardiectomy

10.Pericardium Diseases Market - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Hospital & clinics
    • 10.1.3.Ambulatory centers
    • 10.1.4.Others

11.Pericardium Diseases Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Pericardium Diseases Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Pericardium Diseases Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Pericardium Diseases Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Pericardium Diseases Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Pericardium Diseases Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Treatment Approach, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Pericardium Diseases Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Kiniksa Pharmaceuticals
    • 12.2.2.Pfizer Inc.
    • 12.2.3.Medtronic
    • 12.2.4.Bayer AG
    • 12.2.5.AstraZeneca Plc
    • 12.2.6.Sanofi
    • 12.2.7.Johnson and Johnson Services, Inc.
    • 12.2.8.Merck & Co., Inc.
    • 12.2.9.Allergan Plc.
    • 12.2.10.Novartis AG
    • 12.2.11.Perkin Elmer Inc.
    • 12.2.12.Integra Lifesciencesk
    • 12.2.13.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us